A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.
about
Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine.An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates.HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivoHIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunitySoluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge modelSynthetic DNA approach to cytomegalovirus vaccine/immune therapyA synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.Vaccine Platforms to Control Arenaviral Hemorrhagic FeversVaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA VaccineSynthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liverHydrodynamic immunization leads to poor CD8 T-cell expansion, low frequency of memory CTLs and ineffective antiviral protectionCyclophilin A as a potential genetic adjuvant to improve HIV-1 Gag DNA vaccine immunogenicity by eliciting broad and long-term Gag-specific cellular immunity in mice.Cytomegalovirus Vaccines: Current Status and Future Prospects.Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.
P2860
Q30360232-0D382773-818C-4A11-B0C1-605656276E5BQ30375785-CE6870C4-3C39-41E2-9437-A5E69BEB583CQ35082880-BF008653-8859-4E9F-858E-2DB10B195F1FQ35108680-D62B9E0D-0D8D-499B-9E27-3F148D677D8EQ35661163-0ED13749-4FDD-4E2B-AC60-FDF75A05FEE3Q35826774-F6B73971-77EA-4DF4-970A-6F75FECE5C9CQ35988587-CC448488-92F6-4CBC-8A8E-45DED0D11DADQ36069582-84850BF3-9280-46CD-9FC2-8E8BD045D88DQ36069589-52B9D77F-3875-4D0C-8A90-7C8D2B676C9CQ36228884-575EC6F7-4E22-4D22-9643-520B25A0AC04Q36612929-474224B7-D979-461D-8773-D959C4D65BF7Q36694861-05BB59D6-6957-4AFD-BF64-08E7A682CCACQ36837548-DAA1EE0F-3327-477C-ADA1-563478E2E5E0Q36871557-E03F760B-2389-46DE-A347-CFA5356CB8C9Q37250507-557DE29A-FDA4-4265-95F2-BC5B342684FDQ37309264-A87B7CB0-6CBE-4FFA-B6B5-1090554824C1Q38791353-0246ABAC-AFE3-454B-A5D7-0A82676D9A43Q39102732-C57264ED-1D4A-4361-81D8-F840834E922BQ52586088-CA0BA1FC-AABD-401D-A832-6389BB91787A
P2860
A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A highly optimized DNA vaccine ...... riomeningitis virus challenge.
@ast
A highly optimized DNA vaccine ...... riomeningitis virus challenge.
@en
type
label
A highly optimized DNA vaccine ...... riomeningitis virus challenge.
@ast
A highly optimized DNA vaccine ...... riomeningitis virus challenge.
@en
prefLabel
A highly optimized DNA vaccine ...... riomeningitis virus challenge.
@ast
A highly optimized DNA vaccine ...... riomeningitis virus challenge.
@en
P2093
P2860
P1433
P1476
A highly optimized DNA vaccine ...... oriomeningitis virus challenge
@en
P2093
Amir S Khan
Bernadette Ferraro
Christina Cress
David B Weiner
Devon J Shedlock
Karthik Mallilankaraman
Kendra T Talbott
Matthew P Morrow
Neil J Cisper
P2860
P304
P356
10.1016/J.VACCINE.2010.12.064
P407
P577
2011-01-14T00:00:00Z